Biocryst Pharmaceuticals Inc (BCRX)
SG&A Expense Growth
-32.34%
Quarterly · Period ending:
BCRX SG&A Expense Growth
Latest reported-32.34%period ending
Latest reported-32.34%period ending
BCRX Quarterly SG&A Growth (QoQ) (0.00% → -32.34%)
Latest values, visible window
High-resolution chart · PNG
BCRX sg&a expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| -32.3392% | |
| -1.281% | |
| 15.3793% | |
| -4.9998% | |
| 5.9586% | |
| 2.4842% | |
| 23.6402% | |
| 6.2613% | |
| 2.9551% | |
| -7.5968% | |
| 27.1166% | |
| -0.6844% | |
| 6.539% | |
| -4.5581% | |
| 35.846% | |
| -2.8882% | |
| 10.8949% | |
| -3.1226% | |
| 1.1288% | |
| 32.9231% | |
| 19.0422% | |
| 5.375% | |
| 22.0471% | |
| 23.8565% | |
| -12.4929% | |
| 51.2537% | |
| -10.6178% | |
| 35.5237% | |
| 38.8105% | |
| 38.931% | |
| -43.3295% | |
| -16.5297% | |
| 24.747% | |
| 61.9625% | |
| 40.5325% | |
| 17.9605% | |
| -7.325% | |
| 19.4065% | |
| -7.0755% | |
| 1.1747% | |
| -15.193% | |
| 18.0448% | |
| -0.3662% | |
| -22.7221% | |
| -12.9771% | |
| 98.291% | |
| 13.0243% | |
| -9.9851% | |
| 26.7632% | |
| 25.0394% | |
| -5.0112% | |
| 8.6109% | |
| -10.9262% | |
| -28.3567% | |
| 13.1378% | |
| 5.9664% | |
| -9.6575% | |
| 68.8152% | |
| -67.855% | |
| -18.0115% | |
| 0.025% | |
| 18.417% | |
| -10.8995% | |
| 18.1988% | |
| -15.4859% | |
| 4.1076% | |
| 19.0335% | |
| 32.4687% | |
| -5.8608% | |
| 3.3992% | |
| -3.8354% | |
| -7.3143% | |
| -7.623% | |
| 16.0919% | |
| -4.2018% | |
| 28.9121% | |
| -15.1349% | |
| 45.4882% | |
| 1.962% | |
| 15.5347% | |
| -7.4247% | |
| 1.8168% | |
| 84.6947% | |
| 9.3535% | |
| 4.454% | |
| -22.4354% | |
| 23.2577% | |
| -21.3823% | |
| 40.303% | |
| -41.3333% | |
| 113.8783% | |
| -4.8825% | |
| -8.8962% | |
| 8.4308% | |
| -14.5337% | |
| -24.7991% | |
| 13.4115% | |
| -23.7406% | |
| 46.1668% | |
| -20.3468% |